Boston Scientific Sells Fluid Management, Venous Access Units
This article was originally published in The Gray Sheet
Executive Summary
Private equity firm Avista Capital Partners plans to operate Boston Scientific's combined fluid management and venous access units as a stand-alone company after acquiring the businesses for $425 million on Dec. 13